Filtered By:
Vaccination: Whooping Cough (Pertussis) Vaccine
Countries: Australia Health
This page shows you your search results in order of date.
Order by Relevance | Date
Total 32 results found since Jan 2013.
Influenza and pertussis vaccine coverage in pregnancy in Australia, 2016-2021
Med J Aust. 2023 May 29. doi: 10.5694/mja2.51989. Online ahead of print.ABSTRACTVaccination in pregnancy is the best strategy to reduce complications from influenza or pertussis infection in infants who are too young to be protected directly from vaccination. Pregnant women are also at risk of influenza complications preventable through antenatal vaccination. Both vaccines are funded under the National Immunisation Program for pregnant women in Australia, but coverage is not routinely reported nationally. We reviewed all reported Australian maternal influenza and pertussis vaccine coverage data for the period 2016-2021, to...
Source: Med J Aust - May 30, 2023 Category: General Medicine Authors: Jocelynne E McRae Lisa McHugh Catherine King Frank H Beard Christopher C Blyth Margie H Danchin Michelle L Giles Hassen Mohammed Nicholas Wood Kristine Macartney Source Type: research
Mapping the delivery of interventions for vaccine-preventable infections in pregnancy in Victoria, Australia
CONCLUSION: Coordinated and standardised system and clinical care improvements are required to provide equitable care for pregnant women and their infants, including training and education for healthcare providers, improving data capture and communication among health services.PMID:36740448 | DOI:10.1071/PY22158
Source: Primary Care - February 5, 2023 Category: Primary Care Authors: Nafisa Yussf Nicole Allard Nicole Romero Ann Wilson Jack Wallace Meg Perrier Stacey Rowe Rosemary Morey Neylan Aykut Benjamin Cowie Source Type: research
Non-specific effects of BCG and DTP vaccination on infant mortality: An analysis of birth cohorts in Ghana and Tanzania
CONCLUSION: We demonstrated that BCG and DTP vaccination were associated with decreased risk of infant mortality in Ghana and Tanzania with no evidence of interaction between DTP or BCG vaccination, NVAS, and infant sex. Our study supports global recommendations on BCG and DTP vaccination and programmatic efforts to ensure all children have access to timely vaccination.CLINICAL TRIALS REGISTRATION: Ghana (Australian New Zealand Clinical Trials Registry (ANZCTR): ACTRN12610000582055) and Tanzania (ANZCTR: ACTRN12610000636055).PMID:35618557 | DOI:10.1016/j.vaccine.2022.04.082
Source: Vaccine - May 26, 2022 Category: Allergy & Immunology Authors: M K Quinn Karen M Edmond Wafaie W Fawzi Lisa Hurt Betty R Kirkwood Honorati Masanja Alfa J Muhihi Sam Newton Ramadhani A Noor Paige L Williams Christopher R Sudfeld Emily R Smith Source Type: research
Pertussis burden and acellular pertussis vaccine effectiveness in high risk children
CONCLUSIONS: For most Aboriginal and non-Aboriginal children, improved timeliness of current infant doses and higher antenatal coverage should further improve protection against pertussis of any severity. For children at highest risk of severe pertussis (born <32 weeks gestation or with significant medical comorbidities), our data suggest that additional measures-such as extra doses of pertussis-containing vaccines and/or vaccines with improved immunogenicity-are needed for protection.PMID:35101268 | DOI:10.1016/j.vaccine.2021.10.013
Source: Vaccine - February 1, 2022 Category: Allergy & Immunology Authors: Sarah Sheridan Peter McIntyre Bette Liu Parveen Fathima Thomas Snelling Christopher Blyth Nicholas de Klerk Hannah Moore Heather Gidding Linkage Investigator Team Source Type: research
Exploring electronic health records to estimate the extent of catch-up immunisation and factors associated with under-immunisation among refugees and asylum seekers in south east Queensland
CONCLUSION: This study indicates that the broader group of immigrants, and in particular refugees and asylum seekers, do not represent a homogenous group in terms of immunisation coverage, and that each cohort should be carefully considered during immunisation interventions and strategies. This will be particularly important during targeted health promotions and future immunisation programs in this cohort.PMID:34556368 | DOI:10.1016/j.vaccine.2021.09.026
Source: Vaccine - September 24, 2021 Category: Allergy & Immunology Authors: Mercy Moraa Nyanchoga Patricia Lee Gaery Barbery Source Type: research
National predictors of influenza vaccine uptake in pregnancy: the FluMum prospective cohort study, Australia, 2012-2015
Conclusions and implications for public health: Healthcare provider discussions with pregnant women about the risks associated with influenza infection during pregnancy and early infancy and evidence about the safety and effectiveness of IIV are required. Recommending and offering IIV in pregnancy needs to be included in these discussions to improve uptake.PMID:34411398 | DOI:10.1111/1753-6405.13130
Source: Australian and New Zealand Journal of Public Health - August 19, 2021 Category: International Medicine & Public Health Authors: Lisa McHugh Kerry-Ann F O'Grady Terry Nolan Peter C Richmond Nicholas Wood Helen S Marshall Stephen B Lambert Mark D Chatfield Kirsten P Perrett Paula Binks Michael J Binks Ross M Andrews Source Type: research
